Starting Monday, California will ship two free emergency albuterol inhalers and 25 spacers to each of roughly 10,000 public and charter schools — the funded, centralized version of a permission the state granted schools back in January 2024 but never paid for.

Gov. Gavin Newsom's "School Albuterol Access Initiative," announced Aug. 20, is being sold as a nationwide first: free rescue inhalers, at no cost for three years, through the state's CalRx generic-drug program. But the more useful way to read it is as the state finally removing the two obstacles that kept its own 2023 law from working — money and paperwork. Schools have been legally allowed to stock non-patient-specific albuterol since 2024; most had to arrange their own standing order and buy the medication themselves. This initiative funds the supply and replaces the per-school prescription hunt with a single statewide standing order — but a school still has to apply to get any of it.

The medication itself is unglamorous and lifesaving. Albuterol relaxes the airways during an asthma attack; the governor's office estimates about 1 million California children have asthma and that one in three with active symptoms misses at least a week of school a year. Under the plan the governor's office announced Aug. 20, CalRx is partnering with Amneal Pharmaceuticals to send each participating TK–12 public or charter school two 90-microgram metered-dose inhalers and 25 single-use spacers, free, once a year for three years. Per the CalRx program page↗ (external source, opens in a new tab), ordering opens Aug. 25 through a centralized system, and schools can buy refills at $9.50 an inhaler — roughly 80% below the cash price.

What makes this more than a press release is the gap it closes. A 2023 law, Assembly Bill 1283↗ (external source, opens in a new tab), added Section 49414.7 to the Education Code, effective January 2024. It let schools voluntarily keep a stock inhaler that isn't tied to any one student, and let trained staff use it in an emergency. The catch: participation was optional, it required a health provider's standing order, and it came with no funding. A district that wanted to comply had to find a physician to sign off and cover the cost itself.

The new initiative hands schools both missing pieces. Dr. Erica Pan, the state public health officer, has signed a statewide albuterol standing order, so individual schools no longer need their own prescription — they apply once through the California Department of Public Health. And the 2025–26 budget covers the medication. In practice that turns a right schools rarely exercised into a supply that shows up in the mail.

The carve-outs are worth naming, because "every school" isn't quite the whole story. Private schools are excluded from the free supply — Education Code 49414.7(c) bars state funds for them — though they can buy the same inhalers from CalRx at cost. Childcare programs and preschools are out entirely for now; albuterol isn't FDA-approved under age 4, and a pending bill, SB 1347, would be needed to bring them in. And nothing here is automatic: a school still has to apply for the standing order and opt into ordering. Districts that never bothered under the 2023 law could still sit out a free program.

There's also a reason to hold the "nationwide first" framing at arm's length. CalRx's flagship product — state-branded insulin — is a cautionary tale about the distance between a Newsom announcement and a drug in someone's hands. Seven months after that insulin brand launched, uptake has been limited↗ (external source, opens in a new tab), KFF Health News reported this month — the state has distributed about 120,000 five-pen packs, which one USC health-policy expert called "largely symbolic." Inhalers are a simpler supply problem than a biosimilar drug label, and the medication already exists on the market — but the initiative's success will be measured in how many of the 10,000 schools actually enroll before the three years of free medication run out.

The lead on this rollout reached The Dissent through SFGATE's pickup of an EdSource item carried by Bay City News; the reporting above is drawn independently from the governor's office, the CalRx program pages, and the underlying statute.